MA07.05 Immune Checkpoint Inhibitor (ICPi) Re-Challenge: Outcomes Analysis in a French National Cohort of Non-Small-Cell Lung Cancer (NSCLC) Patients

Autor: Gobbini, E., Toffart, A.C., Perol, M., Assié, J., Duruisseaux, M., Coupez, D., Gervais, R., Westeel, V., Delaunay, M., Guisier, F., Veillon, R., Gounant, V., Leprieur, E. Giroux, Vanel, F.R., Chaabane, N., Dansin, E., Babey, H., Decroisette, C., Barlesi, F., Girard, N., Fournel, P., Mezquita, L., Oulkhouir, Y., Canellas, A., Duchemann, B., Molinier, O., Moro-Sibilot, D., Levra, M. Giaj
Zdroj: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S274-S274
Databáze: ScienceDirect